These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2884858)

  • 1. Effects of alpha 1 inhibition on renal blood flow and sympathetic nervous activity in systemic hypertension.
    Wilner KD; Ziegler MG
    Am J Cardiol; 1987 May; 59(14):82G-86G. PubMed ID: 2884858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-adrenoceptor blockade in patients with mild to moderate hypertension: long-term renal effects of doxazosin.
    Krusell LR; Christensen CK; Pedersen OL
    J Cardiovasc Pharmacol; 1992 Sep; 20(3):440-4. PubMed ID: 1279290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute renal effects of doxazosin in man.
    de Leeuw PW; van Es PN; De Bos R; Birkenhäger WH
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):41S-43S. PubMed ID: 2939866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of alpha 1- and alpha 2-adrenergic receptors in the human hypertensive kidney.
    de Leeuw PW; van Es PN; de Bos R; Birkenhäger WH
    Hypertension; 1987 Jun; 9(6 Pt 2):III210-2. PubMed ID: 2885275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multicentre 12-week double-blind comparison of doxazosin, prazosin and placebo in patients with mild to moderate essential hypertension.
    Torvik D; Madsbu HP
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):69S-75S. PubMed ID: 2939870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind parallel trial to assess the efficacy of doxazosin, atenolol and placebo in patients with mild to moderate systemic hypertension.
    Nash DT; Schonfeld G; Reeves RL; Black H; Weidler DJ
    Am J Cardiol; 1987 May; 59(14):87G-90G. PubMed ID: 2884859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension.
    Pool JL
    Am J Cardiol; 1987 May; 59(14):46G-50G. PubMed ID: 2884853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Terazosin: ex vivo and in vitro platelet aggregation effects in patients with arterial hypertension.
    Hernández Hernández R; Angeli-Greaves M; Carvajal AR; Guerrero Pajuelo J; Armas Padilla MC; Armas-Hernández MJ
    Am J Hypertens; 1996 May; 9(5):437-44. PubMed ID: 8735174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of doxazosin and atenolol on smoking-induced peripheral vasoconstriction in hypertensive habitual smokers.
    Lecerof H; Bornmyr S; Lilja B; De Pedis G; Hulthén UL
    J Hypertens Suppl; 1990 Sep; 8(5):S29-33. PubMed ID: 1981074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacologic basis for the use of doxazosin in the treatment of essential hypertension.
    Davey MJ
    Am J Med; 1989 Aug; 87(2A):36S-44S. PubMed ID: 2569823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antihypertensive effect of doxazosin in hypertensive patients: comparison with atenolol.
    Baez MA; Garg DC; Jallad NS; Weidler DJ
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):63S-67S. PubMed ID: 2939869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of doxazosin in systemic hypertension.
    Ames RP; Chrysant SG; Gonzalez F; Schnaper HW; Spann S; Velasquez MT
    Am J Cardiol; 1989 Jul; 64(3):203-8. PubMed ID: 2525870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic haemodynamic effects of doxazosin in hypertension at rest and during exercise.
    Lund-Johansen P; Omvik P; Haugland H
    Br J Clin Pharmacol; 1986; 21 Suppl 1(Suppl 1):45S-54S. PubMed ID: 2939867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-1 adrenoceptor blockade with doxazosin in hypertension: effects on blood pressure and lipoproteins.
    Ames RP; Kiyasu JY
    J Clin Pharmacol; 1989 Feb; 29(2):123-7. PubMed ID: 2565917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of doxazosin and hydralazine on insulin sensitivity and sympathetic function in spontaneously hypertensive rat (SHR)].
    Takahashi A; Kushiro T; Kanmatsuse K
    Nihon Jinzo Gakkai Shi; 1998 May; 40(4):240-4. PubMed ID: 9654906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neural mechanisms in primary hypertension. Efficacy of alpha-blockade with doxazosin during stress.
    Lee D; Lu ZW; DeQuattro V
    Am J Hypertens; 1996 Jan; 9(1):47-53. PubMed ID: 8834706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of the effects of doxazosin and terazosin on the spontaneous sympathetic drive to the bladder and related organs in anaesthetized cats.
    Ramage AG; Wyllie MG
    Eur J Pharmacol; 1995 Dec; 294(2-3):645-50. PubMed ID: 8750729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.
    Elliott HL; Meredith PA; Sumner DJ; McLean K; Reid JL
    Br J Clin Pharmacol; 1982 May; 13(5):699-703. PubMed ID: 6123342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of sympathetic stimulation and intrarenal alpha-blockade on the secretion of renin by the human kidney.
    de Leeuw PW; de Bos R; van Es PN; Birkenhäger WH
    Eur J Clin Invest; 1985 Aug; 15(4):166-70. PubMed ID: 2995048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multicenter, double-blind comparison of doxazosin and atenolol in patients with mild to moderate hypertension.
    Ott P; Storm TL; Krusell LR; Jensen H; Badskjaer J; Faergeman O
    Am J Cardiol; 1987 May; 59(14):73G-77G. PubMed ID: 2884856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.